Form 8-K - Current report:
SEC Accession No. 0001104659-12-086948
Filing Date
2012-12-31
Accepted
2012-12-31 17:28:35
Documents
1
Period of Report
2012-12-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a12-30364_18k.htm 8-K 19458
  Complete submission text file 0001104659-12-086948.txt   20850
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 121294047
SIC: 2834 Pharmaceutical Preparations